These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11502439)

  • 1. Antiandrogen monotherapy: a new form of treatment for patients with prostate cancer.
    Kolvenbag GJ; Iversen P; Newling DW
    Urology; 2001 Aug; 58(2 Suppl 1):16-23. PubMed ID: 11502439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiandrogen monotherapy: indications and results.
    Iversen P
    Urology; 2002 Sep; 60(3 Suppl 1):64-71. PubMed ID: 12231053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
    Sciarra A; Cardi A; Di Silverio F
    Urol Int; 2004; 72(2):91-8. PubMed ID: 14963347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiandrogen monotherapy in the management of advanced prostate cancer.
    Kaisary AV
    Eur Urol; 1997; 31 Suppl 2():14-9; discussion 24-7. PubMed ID: 9074906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of antiandrogen monotherapy in the treatment of prostate cancer.
    Anderson J
    BJU Int; 2003 Mar; 91(5):455-61. PubMed ID: 12603397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.
    Iversen P; Tyrrell CJ; Kaisary AV; Anderson JB; Van Poppel H; Tammela TL; Chamberlain M; Carroll K; Melezinek I
    J Urol; 2000 Nov; 164(5):1579-82. PubMed ID: 11025708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiandrogens as monotherapy for prostate cancer.
    Schröder FH
    Eur Urol; 1998; 34 Suppl 3():12-7. PubMed ID: 9854190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.
    Kunath F; Grobe HR; Rücker G; Motschall E; Antes G; Dahm P; Wullich B; Meerpohl JJ
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009266. PubMed ID: 24979481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nilutamide: an antiandrogen for the treatment of prostate cancer.
    Dole EJ; Holdsworth MT
    Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?
    Boccon-Gibod L
    Eur Urol; 1998; 33(2):159-64. PubMed ID: 9519357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.
    Mahler C; Verhelst J; Denis L
    Clin Pharmacokinet; 1998 May; 34(5):405-17. PubMed ID: 9592622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
    Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
    Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicalutamide monotherapy for early stage prostate cancer: an update.
    Iversen P
    J Urol; 2003 Dec; 170(6 Pt 2):S48-52; discussion S52-4. PubMed ID: 14610410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma.
    Chodak G; Sharifi R; Kasimis B; Block NL; Macramalla E; Kennealey GT
    Urology; 1995 Dec; 46(6):849-55. PubMed ID: 7502428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicalutamide treatment for locally advanced prostate cancer.
    Anderson J
    Hosp Med; 2000 Sep; 61(9):660-3. PubMed ID: 11048610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.
    Iversen P; Tyrrell CJ; Kaisary AV; Anderson JB; Baert L; Tammela T; Chamberlain M; Carroll K; Gotting-Smith K; Blackledge GR
    Urology; 1998 Mar; 51(3):389-96. PubMed ID: 9510340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer.
    Blackledge G; Kolvenbag G; Nash A
    Anticancer Drugs; 1996 Jan; 7(1):27-34. PubMed ID: 8742095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer.
    Wellington K; Keam SJ
    Drugs; 2006; 66(6):837-50. PubMed ID: 16706554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of locally advanced prostate cancer--a new role for antiandrogen monotherapy?
    Abrahamsson PA
    Eur Urol; 2001; 39 Suppl 1():22-8. PubMed ID: 11114597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.